País: Nova Zelândia
Língua: inglês
Origem: Medsafe (Medicines Safety Authority)
Lamotrigine 100mg
Douglas Pharmaceuticals Limited
Lamotrigine 100 mg
100 mg
Chewable/dispersible tablet
Active: Lamotrigine 100mg Excipient: Calcium carbonate Colloidal silicon dioxide Crospovidone Maize starch Microcrystalline cellulose Purified talc Ribes nigrum Saccharin sodium Sodium stearyl fumarate Sorbitol
Blister pack, PVC/Al blister, 56 tablets
Prescription
Prescription
Jubilant Generics Limited
Package - Contents - Shelf Life: Blister pack, PVC/Al blister - 56 tablets - 36 months from date of manufacture stored at or below 25°C
2006-01-04
Medsafe Logo INFORMATION FOR CONSUMERS Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search Consumer Medicine Information MOGINE Lamotrigine 25 mg, 50 mg, 100 mg and 200 mg dispersible/chewable tablets What is in this leaflet This leaflet answers some common questions about MOGINE. It does not contain all the available information. It does not take the place of talking to your doctor and pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking MOGINE against the benefits this medicine is expected to have for you. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Keep this leaflet with the medicine. You may need to read it again. What MOGINE tablets are used for MOGINE tablets contain the active ingredient lamotrigine. It is used to treat epilepsy in children and adults. MOGINE is used in partial (seizures that affect only one part of the brain) or generalised seizures (seizures that affect the whole brain) including Lennox-Gastaut Syndrome. Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy and is characterised by several seizure types. MOGINE tablets are initially used in addition to other medicines for the treatment of epilepsy. The brain consists of a million nerve cells, or neurons. These neurons receive electrical signals from other neurons and pass them on to the next neurons. The functions of a normal brain depend on the electrical signals being passed from one neuron to the next. The brain constantly generates electrical rhythms in an orderly manner. next. The brain constantly generates electrical rhythms in an orderly manner. Epilepsy is caused by a disruption in the electrical activity of the brain. The abnormal elect Leia o documento completo
MOGINE _LAMOTRIGINE 25 MG, 50 MG, 100 MG AND 200 MG TABLETS _ NAME OF THE DRUG MOGINE Lamotrigine 25 mg, 50 mg, 100 mg and 200 mg tablets. Severe, potentially life-threatening rashes have been reported in association with the use of lamotrigine, particularly in children. Accordingly, lamotrigine should be discontinued at the first sign of rash unless the rash is clearly not drug related. (SEE DOSAGE AND ADMINISTRATION). DESCRIPTION Lamotrigine is a substituted asymmetric triazine. It is a white to pale cream coloured powder. It is slightly soluble in ethanol and chloroform, and very slightly soluble in water. The pKa of lamotrigine at 25 C is 5.7. The chemical name for lamotrigine is 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine. The CAS Number is 84057-84-1 and the molecular weight: 256.1. The structural formula is: MOGINE tablets contain as excipients: calcium carbonate, sorbitol, cellulose- microcrystalline, crospovidone, starch- maize, purified talc, saccharin sodium, sodium stearylfumarate, colloidal anhydrous silica, blackcurrant flavour (ARTG No. 11133). PHARMACOLOGY _MECHANISM OF ACTION _ Lamotrigine is an anticonvulsant and its action is uncertain. The results of neurochemical and electrophysiological studies with various _in vitro_ and _in vivo_ preparations indicate that lamotrigine can inhibit voltage gated sodium channels and reduce the release of glutamate, an excitatory amino acid implicated in the pathophysiology of epilepsy. It is possible that these effects underlie inhibition of the sustained repetitive firing of action potentials characteristic of neurones in epileptic foci, thereby limiting the spread of seizures. In tests designed to evaluate the central nervous system effects of drugs, the results obtained using doses of 240 mg lamotrigine administered to healthy male and female volunteers did not differ from placebo, whereas both 1000 mg phenytoin and 10 mg diaze Leia o documento completo